Paul Note
HEC Paris
Former CEO of Geistlich Pharma AG
Geistlich, Osteology Foundation, flowbone SA, Wyss Zurich
Dr. Michele Pedrocchi
Msc (Biochemistry and Cell Biology) ETH
25+ years executive roles in Commercial Execution, Strategy & BD at Roche, Board Director and Independent Advisor in Diagnostics
Roche, Emminens Healthcare
Dr. Daniel E. Schaufelberger
Pharmacist, ETH
Sr. Scientific Director Johnson & Johnson
Professor Johns Hopkins University, All Children's Hospital
Yves Steffen
B.Eng. Process Engineering
CEO Inductio AG
18 years of experience in the pharmaceutical industry
Novartis, Johnson & Johnson, SHL Medical AG